Eagle Bay Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History

Eagle Bay Advisors LLC

$170 Million
Q3 2024

A detailed history of Eagle Bay Advisors LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Eagle Bay Advisors LLC holds 80 shares of REGN stock, worth $56,148. This represents 0.05% of its overall portfolio holdings.

Number of Shares

Previous 81 1.23%

Holding current value

$56,148

Previous $85,000 1.18%

% of portfolio

0.05%

Previous 0.05%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$1024.09 - $1201.76 $1,024 - $1,201	-1 Reduced 1.23%	80 $84,000
Q2 2024 Jul 26, 2024	SELL	$883.2 - $1071.19 $883 - $1,071	-1 Reduced 1.22%	81 $85,000
Q1 2024 May 08, 2024	SELL	$902.69 - $993.35 $1,805 - $1,986	-2 Reduced 2.38%	82 $78,000
Q4 2023 Feb 08, 2024	SELL	$775.18 - $881.7 $775 - $881	-1 Reduced 1.18%	84 $73,000
Q3 2023 Nov 13, 2023	SELL	$692.45 - $844.37 $692 - $844	-1 Reduced 1.16%	85 $69,000
Q2 2023 Aug 10, 2023	BUY	$700.03 - $830.35 $1,400 - $1,660	2 Added 2.38%	86 $61,000
Q1 2023 Apr 24, 2023	SELL	$680.49 - $826.97 $3,402 - $4,134	-5 Reduced 5.62%	84 $69,000
Q4 2022 Jan 26, 2023	SELL	$705.89 - $766.39 $4,941 - $5,364	-7 Reduced 7.29%	89 $0
Q3 2022 Nov 22, 2022	SELL	$573.97 - $724.32 $3,443 - $4,345	-6 Reduced 5.88%	96 $66,000
Q2 2022 Aug 19, 2022	BUY	$548.35 - $738.84 $55,931 - $75,361	102 New	102 $60.3 Million
Q1 2022 May 11, 2022	SELL	$595.12 - $698.43 $64,868 - $76,128	-109 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$543.48 - $670.97 $55,434 - $68,438	-102 Reduced 48.34%	109 $69,000
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $60,273 - $71,500	105 Added 99.06%	211 $128,000
Q2 2021 Jul 30, 2021	BUY	$472.8 - $558.54 $50,116 - $59,205	106 New	106 $61,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Bay Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Bay Advisors LLC with notifications on news.

Account

Eagle Bay Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History